Literature DB >> 15726608

Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF.

George K Anagnostopoulos, George H Sakorafas, Panagiotis Kostopoulos, George Margantinis, Stavros Tsiakos, Evaggelos Terpos, George Pavlakis, Paul Fortun, Dimitrios Arvanitidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15726608     DOI： 10.1002/jso.20173

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  12 in total

1.  Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer.

Authors:  Hiroki Kato; Katsura Kohata; Joji Yamamoto; Satoshi Ichikawa; Mika Watanabe; Kenichi Ishizawa; Ryo Ichinohasama; Hideo Harigae
Journal:  Int J Hematol       Date:  2010-02-05       Impact factor: 2.490

Review 2.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

3.  Impact of chemotherapy on eosinophilia-associated advanced rectal cancer: A case report and review of the literature.

Authors:  Maki Inoue; Jun Kadono; Hiroshi Sugita; Toshihiro Nakazono; Shunsuke Motoi; Iwao Kitazono; Yuko Goto; Yoshihiko Fukukura; Makoto Yoshimitsu; Takaharu Misaka; Yutaka Imoto
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

4.  Marked hypereosinophilia secondary to endometrioid ovarian cancer presenting with asthma symptoms, a case report.

Authors:  Hasan Ahmad Hasan Albitar; Ashley M Egan; Hassan Alkhateeb; Yahya Almodallal; Vivek N Iyer
Journal:  Respir Med Case Rep       Date:  2020-07-28

5.  Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy.

Authors:  Rikke B Holmgaard; Alexandra Brachfeld; Billel Gasmi; David R Jones; Marissa Mattar; Thompson Doman; Mary Murphy; David Schaer; Jedd D Wolchok; Taha Merghoub
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

6.  Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

Authors:  Tilman Todenhöfer; Stefan Wirths; Claus Hann von Weyhern; Stefan Heckl; Marius Horger; Joerg Hennenlotter; Arnulf Stenzl; Lothar Kanz; Christian Schwentner
Journal:  BMC Urol       Date:  2012-03-21       Impact factor: 2.264

7.  GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression.

Authors:  Claudia M Gutschalk; Archana K Yanamandra; Nina Linde; Alice Meides; Sofia Depner; Margareta M Mueller
Journal:  Cancer Med       Date:  2012-11-26       Impact factor: 4.452

8.  Rapidly evolving asymptomatic eosinophilia in a patient with lung adenocarcinoma causes cognitive disturbance and respiratory insufficiency: Case report.

Authors:  Cheng-Hsiang Lo; Yee-Min Jen; Wen-Chiuan Tsai; Ping-Ying Chung; Woei-Yau Kao
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

9.  Chromophobe renal cell carcinoma associated with eosinophilia: A report of three cases.

Authors:  Yong-Bao Wei; Bin Yan; Zhuo Yin; Jin-Rui Yang
Journal:  Exp Ther Med       Date:  2014-05-20       Impact factor: 2.447

10.  Mucoepidermoid carcinoma of parotid gland and membranous nephropathy - differentiation between sclerosing mucoepidermoid carcinoma with eosinophilia and Kimura's disease.

Authors:  Hayato Fujioka; Tsutomu Koike; Teruhiko Imamura; Kota Kakeshita; Hidenori Yamazaki; Hideharu Abe; Takahiko Nakajima; Koichiro Kinugawa
Journal:  BMC Nephrol       Date:  2020-08-26       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.